Director Business Development MedTech @ (December 2019 - January 2026)
Director Strategic Marketing @ (January 2018 - December 2019)
Strategic Market Development Manager @ Cepheid (January 2017 - December 2017)
Head of Marketing and Marketing Manager @ Cepheid (June 2012 - January 2017)
Key Account Manager @ (February 2007 - June 2012)
Senior Product Manager @ (January 2006 - January 2007)
Product Manager @ (October 2001 - March 2006)
Product Manager @ (November 1999 - October 2001)
Sales Rep @ (January 1997 - January 1999)
Claudio Priscoglio Education
Faculty of Management, Comenius University in Bratislava
Doctor of Philosophy - PhD (Business Administration and Management, General)
2011-2019
Hochschule Karlsruhe - Technik und Wirtschaft / University Of Applied Sciences
Dipl.-Wirt.ing. (Wirtschaftsingenieur)
1992-1997
Claudio Priscoglio Skills
Market Development
Medical Devices
Marketing
Product Launch
Infectious Diseases
Molecular Biology
Biotechnology
Commercialization
Cross-functional Team Leadership
Strategic Planning
Cross Functional Team
Product Development
Business Development
Public Speaking
Cross Functional Team Leadership
Biomedical Engineering
Management
Sales Operations
Pharmaceutical Industry
Life Sciences
Product Management
Biology
Strategy
Account Management
Claudio Priscoglio Summary
Claudio Priscoglio, based in Frankfurt, HE, DE, is currently a Sales Lead Germany at Improve International. Claudio Priscoglio brings experience from previous roles at Available for Strategic Advisory, Interim Leadership and Fractional Executive as, Habmann AufstiegsAkademie, IQVIA and POLYTECH Health & Aesthetics. Claudio Priscoglio holds a 2011 - 2019 Doctor of Philosophy - PhD in Business Administration and Management, General @ Faculty of Management, Comenius University in Bratislava. With a robust skill set that includes Market Development, Medical Devices, Marketing, Product Launch, Infectious Diseases and more. Claudio Priscoglio has 2 emails on RocketReach.
Looking for a different Claudio Priscoglio?
Find contact details for 700 million professionals.